Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism A Zanchi, DK Moczulski, LS Hanna, M Wantman, JH Warram, ... Kidney international 57 (2), 405-413, 2000 | 271 | 2000 |
Poly (ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity C Szabó, A Zanchi, K Komjáti, P Pacher, AS Krolewski, WC Quist, ... Circulation 106 (21), 2680-2686, 2002 | 207 | 2002 |
Blockade of the renin–angiotensin–aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes M Burnier, A Zanchi Journal of hypertension 24 (1), 11-25, 2006 | 150 | 2006 |
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system A Zanchi, NC Schaad, MC Osterheld, E Grouzmann, J Nussberger, ... American Journal of Physiology-Heart and Circulatory Physiology 268 (6 …, 1995 | 144 | 1995 |
Effects of the peroxisomal proliferator-activated receptor-γ agonist pioglitazone on renal and hormonal responses to salt in healthy men A Zanchi, A Chiolero, M Maillard, J Nussberger, HR Brunner, M Burnier The Journal of Clinical Endocrinology & Metabolism 89 (3), 1140-1145, 2004 | 122 | 2004 |
Antidiabetic drugs and kidney disease A Zanchi, R Lehmann, J Philippe Swiss medical weekly 142 (3738), w13629-w13629, 2012 | 93 | 2012 |
Activation of electrical triggers of atrial fibrillation in hyperthyroidism K Wustmann, JP Kucera, A Zanchi, A Burow, T Stuber, B Chappuis, ... The Journal of Clinical Endocrinology & Metabolism 93 (6), 2104-2108, 2008 | 84 | 2008 |
Acute and chronic effects of SGLT2 inhibitor empagliflozin on renal oxygenation and blood pressure control in nondiabetic normotensive subjects: a randomized, placebo … A Zanchi, M Burnier, ME Muller, A Ghajarzadeh‐Wurzner, M Maillard, ... Journal of the American Heart Association 9 (13), e016173, 2020 | 74 | 2020 |
Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase JA Haefliger, P Meda, A Formenton, P Wiesel, A Zanchi, HR Brunner, ... Arteriosclerosis, thrombosis, and vascular biology 19 (7), 1615-1622, 1999 | 67 | 1999 |
Recent clinical trials with omapatrilat: new developments A Zanchi, M Maillard, M Burnier Current hypertension reports 5 (4), 346-352, 2003 | 66 | 2003 |
Evidence against a direct role of klotho in insulin resistance O Lorenzi, C Veyrat-Durebex, CB Wollheim, P Villemin, ... Pflügers Archiv-European Journal of Physiology 459, 465-473, 2010 | 62 | 2010 |
Blockade of the renin–angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes M Pruijm, L Hofmann, A Zanchi, M Maillard, V Forni, ME Muller, ... Diabetes research and clinical practice 99 (2), 136-144, 2013 | 52 | 2013 |
Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties A Zanchi, AG Dulloo, C Perregaux, JP Montani, M Burnier American Journal of Physiology-Endocrinology and Metabolism 293 (1), E91-E95, 2007 | 49 | 2007 |
Health status and quality of life in patients with diabetes in Switzerland C Arditi, A Zanchi, I Peytremann-Bridevaux Primary care diabetes 13 (3), 233-241, 2019 | 44 | 2019 |
Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats A Zanchi, P Wiesel, JF Aubert, HR Brunner, D Hayoz Hypertension 29 (5), 1199-1203, 1997 | 42 | 1997 |
Endotheliai function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia A Zanchi, E Delacrétaz, V Taleb, R Gaillard, B Jeanrenaud, HR Brunner, ... Journal of hypertension 13 (12), 1463-1470, 1995 | 38 | 1995 |
The impact of a multidisciplinary self-care management program on quality of life, self-care, adherence to anti-hypertensive therapy, glycemic control, and renal function in … N Helou, D Talhouedec, M Shaha, A Zanchi BMC nephrology 17, 1-10, 2016 | 37 | 2016 |
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis N Helou, A Dwyer, M Shaha, A Zanchi JBI Evidence Synthesis 14 (7), 169-207, 2016 | 36 | 2016 |
Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals A Zanchi, M Maillard, FR Jornayvaz, M Vinciguerra, P Deleaval, ... Diabetologia 53, 1568-1575, 2010 | 32 | 2010 |
Differences in the mechanical properties of the rat carotid artery in vivo, in situ, and in vitro A Zanchi, N Stergiopulos, HR Brunner, D Hayoz Hypertension 32 (1), 180-185, 1998 | 32 | 1998 |